Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Humana Inc.

Start price
Target price
Perf. (%)
€475.10
28.02.23
€528.84
28.02.24
-31.87%
29.02.24

buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€450.10
28.02.23
€569.31
28.02.24
1.53%
29.02.24

buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€450.10
28.02.23
€569.31
28.02.24
1.53%
29.02.24

buy
Cigna Corp.

Start price
Target price
Perf. (%)
€274.75
28.02.23
€348.17
28.02.24
12.76%
29.02.24

buy
Henry Schein Inc.

Start price
Target price
Perf. (%)
€74.17
28.02.23
€91.27
28.02.24
-4.57%
29.02.24

buy
Henry Schein Inc.

Start price
Target price
Perf. (%)
€74.17
28.02.23
€91.27
28.02.24
-4.57%
29.02.24

buy
Amedisys Inc.

Start price
Target price
Perf. (%)
€85.50
28.02.23
€108.15
28.02.24
-0.58%
29.02.24

buy
Addus Homecare Corp.

Start price
Target price
Perf. (%)
€100.00
28.02.23
-
28.02.24
-16.50%
29.02.24

buy
Gerresheimer AG

Start price
Target price
Perf. (%)
€83.95
28.02.23
-
28.02.24
13.04%
31.01.24

buy
Omnicell Inc.

Start price
Target price
Perf. (%)
€50.50
27.02.23
€64.25
27.02.24
-52.48%
28.02.24

buy
Iridex Corp.

Start price
Target price
Perf. (%)
€6.10
26.02.23
-
26.02.24
-
27.02.24

buy
Pro-Dex Inc.

Start price
Target price
Perf. (%)
€14.00
26.02.23
-
26.02.24
7.86%
27.02.24

buy
Orpea Nom.

Start price
Target price
Perf. (%)
€2.58
20.02.23
-
20.02.24
-1.16%
05.03.23

Could be very worthwhile Investment >20% year
buy
Orpea Nom.

Start price
Target price
Perf. (%)
€2.17
08.02.23
-
08.02.24
-9.35%
03.04.23

Could be very worthwhile Investment >20% year
buy
Orpea Nom.

Start price
Target price
Perf. (%)
€2.36
07.02.23
€4.00
07.02.24
9.32%
18.02.23

Could be very worthwhile Investment >20% year
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Orpea Nom.

Start price
Target price
Perf. (%)
€2.87
05.02.23
-
05.02.24
-10.07%
18.02.23

Could be very worthwhile Investment >20% year
buy
Sientra Inc.

Start price
Target price
Perf. (%)
€1.84
02.02.23
€3.60
02.02.24
-4.62%
06.02.23

Could be very worthwhile Investment >20% year
buy
Orpea Nom.

Start price
Target price
Perf. (%)
€5.54
01.02.23
-
01.02.24
-48.21%
05.02.23

Could be very worthwhile Investment >20% year
buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€2.16
10.01.23
€4.00
31.12.25
-46.57%
05.05.23

Could be very worthwhile Investment >20% year
buy
Drägerwerk AG & Co. KGaA VZO

Start price
Target price
Perf. (%)
€43.10
09.01.23
-
09.01.24
-0.35%
21.01.23

Market Leader or Top 3
Well known brand
Very Future proof/growth oriented business model
Revenue growth > 30% per year expected
Vyant Bio Inc.

Start price
Target price
Perf. (%)
€1.55
05.01.23
-
05.01.24
-65.81%
02.04.23

buy
HTG Molecular Diagnostics Inc.

Start price
Target price
Perf. (%)
€3.79
27.12.22
-
27.12.23
-90.75%
29.07.23

Capable Management
Risky Investment
No uniques
No Innovation
buy
Hologic Inc.

Start price
Target price
Perf. (%)
€69.65
22.12.22
-
22.12.23
-0.67%
24.08.23

buy
Hologic Inc.

Start price
Target price
Perf. (%)
€69.65
22.12.22
-
22.12.23
-0.67%
24.08.23

HTG Molecular Diagnostics Inc.

Start price
Target price
Perf. (%)
€19.20
12.12.22
€0.000
12.12.23
-63.50%
15.12.22

Capable Management
Risky Investment
No uniques
No Innovation